Jiangbo Pharmaceuticals woos pharma distributor Xinkangqi Medical
This article was originally published in Scrip
Jiangbo Pharmaceuticals, the NASDAQ-quoted Chinese pharma company, has unveiled plans to acquire Xinkangqi Medical, a regional wholesale drug distributor in Shandong Province, the home to 94 million people. A final price will be determined once Jiangbo has completed its due diligence, which is expected to conclude within three months. Jiangbo will retain Xinkangqi's current employees and management team when the acquisition closes by the end of September 2011.